Published in Innate Immun on June 29, 2012
The future of biologic coatings for orthopaedic implants. Biomaterials (2013) 1.53
Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A (2013) 1.18
Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater (2013) 1.15
Bone tumor mimickers: A pictorial essay. Indian J Radiol Imaging (2014) 1.12
Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target. Acta Biomater (2013) 1.09
Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface (2014) 1.01
Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol (2013) 0.99
Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement. Acta Biomater (2014) 0.92
The effects on bone cells of metal ions released from orthopaedic implants. A review. Clin Cases Miner Bone Metab (2013) 0.88
Modulation of mouse macrophage polarization in vitro using IL-4 delivery by osmotic pumps. J Biomed Mater Res A (2014) 0.85
The association between metal allergy, total knee arthroplasty, and revision: study based on the Danish Knee Arthroplasty Register. Acta Orthop (2015) 0.85
Adverse reactions to metal-on-metal implants. Nat Rev Rheumatol (2012) 0.83
The pathobiology and pathology of aseptic implant failure. Bone Joint Res (2016) 0.81
Metallic debris from metal-on-metal total hip arthroplasty regulates periprosthetic tissues. World J Orthop (2014) 0.80
Metal artefact suppression at 3 T MRI: comparison of MAVRIC-SL with conventional fast spin echo sequences in patients with Hip joint arthroplasty. Eur Radiol (2015) 0.80
Innate immune reactions in septic and aseptic osteolysis around hip implants. J Long Term Eff Med Implants (2014) 0.79
Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med (2014) 0.79
Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis. Autophagy (2015) 0.79
Wear particles and ions from cemented and uncemented titanium-based hip prostheses-a histological and chemical analysis of retrieval material. J Biomed Mater Res B Appl Biomater (2014) 0.78
Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions. J Bone Miner Res (2016) 0.77
Gene Expression in Osteolysis: Review on the Identification of Altered Molecular Pathways in Preclinical and Clinical Studies. Int J Mol Sci (2017) 0.77
Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview. J Long Term Eff Med Implants (2014) 0.76
ER Stress Mediates TiAl6V4 Particle-Induced Peri-Implant Osteolysis by Promoting RANKL Expression in Fibroblasts. PLoS One (2015) 0.76
Curcumin Attenuates Titanium Particle-Induced Inflammation by Regulating Macrophage Polarization In Vitro and In Vivo. Front Immunol (2017) 0.75
In vitro assessment of knee MRI in the presence of metal implants comparing MAVRIC-SL and conventional fast spin echo sequences at 1.5 and 3 T field strength. J Magn Reson Imaging (2014) 0.75
Metal Hypersensitivity Reactions to Orthopedic Implants. Dermatol Ther (Heidelb) (2016) 0.75
Long-term survival of the uncemented Balgrist total hip replacement cup. Int Orthop (2013) 0.75
Total elbow arthroplasty is moving forward: Review on past, present and future. World J Orthop (2016) 0.75
Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. Biomaterials (2016) 0.75
Particle Disease: A Current Review of the Biological Mechanisms in Periprosthetic Osteolysis After Hip Arthroplasty. Open Orthop J (2016) 0.75
Immune response and innervation signatures in aseptic hip implant loosening. J Transl Med (2016) 0.75
A novel nano-copper-bearing stainless steel with reduced Cu(2+) release only inducing transient foreign body reaction via affecting the activity of NF-κB and Caspase 3. Int J Nanomedicine (2015) 0.75
Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo. Biosci Rep (2016) 0.75
Monoblock versus modular polyethylene insert in uncemented total knee arthroplasty. Acta Orthop (2016) 0.75
Biocompatibility of Four Common Orthopedic Biomaterials Following a High-Salt Diet: An In Vivo Study. Int J Mol Sci (2017) 0.75
Immunological Responses to Total Hip Arthroplasty. J Funct Biomater (2017) 0.75
Probiotics protect mice from CoCrMo particles-induced osteolysis. Int J Nanomedicine (2017) 0.75
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 12.08
Origin and physiological roles of inflammation. Nature (2008) 11.68
Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol (2012) 9.75
Foreign body reaction to biomaterials. Semin Immunol (2007) 8.32
Nonresolving inflammation. Cell (2010) 7.74
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol (2011) 6.73
Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol (2004) 5.13
Alarmins: chemotactic activators of immune responses. Curr Opin Immunol (2005) 3.57
microRNA regulation of inflammatory responses. Annu Rev Immunol (2012) 3.47
Inflammation 2010: new adventures of an old flame. Cell (2010) 3.05
Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am (1992) 2.58
A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty (2002) 2.41
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 2.38
Stem-cell hierarchy in skin cancer. Nat Rev Cancer (2003) 2.36
Tissue-based class control: the other side of tolerance. Nat Rev Immunol (2011) 2.33
Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum (2008) 2.26
History and systematic review of wear and osteolysis outcomes for first-generation highly crosslinked polyethylene. Clin Orthop Relat Res (2011) 2.10
Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol (2011) 1.98
Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res (1977) 1.87
Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83
Total hip arthroplasties: what are the reasons for revision? Int Orthop (2007) 1.55
Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am (1990) 1.34
Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol (2009) 1.32
Endosteal erosion in association with stable uncemented femoral components. J Bone Joint Surg Am (1990) 1.31
Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand (1994) 1.27
The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop (2009) 1.26
Macrophage proinflammatory activation and deactivation: a question of balance. Adv Immunol (2010) 1.23
Why does chronic inflammation persist: An unexpected role for fibroblasts. Immunol Lett (2011) 1.21
Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol (2010) 1.20
MCM proteins are negative regulators of hypoxia-inducible factor 1. Mol Cell (2011) 1.17
Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials (2011) 1.16
Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials (2010) 1.12
Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Res (2007) 1.10
The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum (2006) 1.08
Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis. Mol Immunol (2009) 1.08
The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res (2005) 1.07
Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol (2011) 1.06
Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res (2003) 1.05
Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J Pathol (2009) 1.04
Macrophage heterogeneity and acute inflammation. Eur J Immunol (2011) 1.01
Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. J Biol Chem (2010) 1.00
Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet (2009) 1.00
A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop Relat Res (1989) 0.98
Fixed or loose? Dichotomy in RSA data for cemented cups. Acta Orthop (2008) 0.98
Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am (2007) 0.97
Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthop Scand (1996) 0.96
Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation. Arthritis Rheum (2010) 0.96
Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res (2011) 0.95
Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen. J Bone Miner Res (2004) 0.95
Biologic activity of wear particles. Instr Course Lect (2010) 0.94
Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing. Acta Orthop Scand (1998) 0.93
Management of acetabular bone loss in revision total hip arthroplasty. J Bone Joint Surg Am (2011) 0.93
Aggressive granulomatous lesions after hip arthroplasty. J Bone Joint Surg Br (1989) 0.92
The histology of the radiolucent line. J Bone Joint Surg Br (1992) 0.92
Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A (2007) 0.92
Early reactive synovitis and osteolysis after total hip arthroplasty. Clin Orthop Relat Res (2010) 0.91
Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis. Apoptosis (2009) 0.91
How have alternative bearings (such as metal-on-metal, highly cross-linked polyethylene, and ceramic-on-ceramic) affected the prevention and treatment of osteolysis? J Am Acad Orthop Surg (2008) 0.91
Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull (2011) 0.90
Evaluation of bone ingrowth in proximally and extensively porous-coated anatomic medullary locking prostheses retrieved at autopsy. J Bone Joint Surg Am (1995) 0.89
Functional variants of the P2RX7 gene, aseptic osteolysis, and revision of the total hip arthroplasty: a preliminary study. Hum Immunol (2009) 0.88
Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. Biomaterials (2005) 0.88
The extent of the bone defect affects the outcome of femoral reconstruction in revision surgery with impacted bone grafting: a five- to 17-year follow-up study. J Bone Joint Surg Br (2011) 0.87
The relationship of polyethylene wear to particle size, distribution, and number: A possible factor explaining the risk of osteolysis after hip arthroplasty. J Biomed Mater Res B Appl Biomater (2010) 0.87
What is the outcome of treatment for osteolysis? J Am Acad Orthop Surg (2008) 0.83
Wear debris stimulates bone-resorbing factor expression in the fibroblasts and osteoblasts. Hip Int (2015) 0.82
Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants. J Orthop Res (2012) 0.81
In vivo murine model of continuous intramedullary infusion of particles--a preliminary study. J Biomed Mater Res B Appl Biomater (2009) 0.80
Studies of host response to orthopedic implants and biomaterials. J Long Term Eff Med Implants (1999) 0.80
IRAK-M in macrophages around septically and aseptically loosened hip implants. J Biomed Mater Res A (2011) 0.79
Influence of demographic, surgical and implant variables on wear rate and osteolysis in ABG I hip arthroplasty. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2006) 0.78
An experimental animal model of aseptic loosening of hip prostheses in sheep to study early biochemical changes at the interface membrane. BMC Musculoskelet Disord (2004) 0.78
The histomorphologic and morphometric study of asymptomatic hip arthroplasty. A postmortem study. Clin Orthop Relat Res (1991) 0.77
Assessing the dog as a model for human total hip replacement: analysis of 38 postmortem-retrieved canine cemented acetabular components. J Biomed Mater Res B Appl Biomater (2005) 0.77
[Is osteolysis associated with a stable total hip replacement asymptomatic?]. Acta Chir Orthop Traumatol Cech (2004) 0.76
Identification of a central role for complement in osteoarthritis. Nat Med (2011) 3.11
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest (2006) 2.10
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81
Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. J Rheumatol (2003) 1.77
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis. J Clin Invest (2011) 1.63
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One (2012) 1.63
Use of polymerase chain reaction to diagnose tuberculous arthritis from joint tissues and synovial fluid. Arch Pathol Lab Med (2004) 1.63
Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum (2011) 1.54
Revision total knee arthroplasty: 1990 through 2002. A review of the Finnish arthroplasty registry. J Bone Joint Surg Am (2006) 1.52
Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop (2009) 1.48
Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.46
Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants. J Rheumatol (2005) 1.46
MC3T3-E1 osteoprogenitor cells systemically migrate to a bone defect and enhance bone healing. Tissue Eng Part A (2012) 1.43
Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs. Clin Rheumatol (2013) 1.42
Corneal innervation and morphology in primary Sjögren's syndrome. Invest Ophthalmol Vis Sci (2003) 1.41
Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty (2008) 1.37
Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37
Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res (2008) 1.36
Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study of 32,019 total knee replacements in the Finnish Arthroplasty Register. Acta Orthop (2010) 1.34
Low rate of infected knee replacements in a nationwide series--is it an underestimate? Acta Orthop (2009) 1.32
New MR imaging methods for metallic implants in the knee: artifact correction and clinical impact. J Magn Reson Imaging (2011) 1.30
The variability of femoral rotational alignment in total knee arthroplasty. J Bone Joint Surg Am (2005) 1.30
Prevention of deep infection in joint replacement surgery. Acta Orthop (2010) 1.28
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
Stem cell homing in musculoskeletal injury. Biomaterials (2010) 1.23
Cell therapy for bone regeneration--bench to bedside. J Biomed Mater Res B Appl Biomater (2009) 1.22
Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater (2012) 1.21
The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng (2007) 1.21
Alternative materials to improve total hip replacement tribology. Acta Orthop Scand (2003) 1.18
Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A (2013) 1.18
Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun (2013) 1.18
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol (2007) 1.17
Mechanoregulation of human articular chondrocyte aggrecan and type II collagen expression by intermittent hydrostatic pressure in vitro. J Orthop Res (2003) 1.17
Effects of hydrostatic pressure and transforming growth factor-beta 3 on adult human mesenchymal stem cell chondrogenesis in vitro. Tissue Eng (2006) 1.17
Bioabsorbable miniplating versus metallic fixation for metacarpal fractures. Clin Orthop Relat Res (2003) 1.17
IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol (2012) 1.16
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol (2002) 1.16
Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials (2011) 1.16
Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices (2008) 1.16
Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles. J Orthop Res (2011) 1.15
Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res (2005) 1.14
Amyloidosis-recent developments. Semin Arthritis Rheum (2008) 1.14
Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. J Arthroplasty (2012) 1.12
Total hip replacement in patients eighty years of age and older. J Bone Joint Surg Am (2008) 1.12
Aseptic versus septic revision total knee arthroplasty: patient satisfaction, outcome and quality of life improvement. Knee (2009) 1.11
A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg (2012) 1.10
Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target. Acta Biomater (2013) 1.09
What is the trouble with trunnions? Clin Orthop Relat Res (2014) 1.09
Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/macrophage activation in vitro. J Biomed Mater Res A (2003) 1.08
The accuracy of preoperative templating in cementless total hip arthroplasty. J Arthroplasty (2008) 1.08
Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum (2009) 1.07
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives. Autoimmun Rev (2011) 1.07
The high variability of tibial rotational alignment in total knee arthroplasty. Clin Orthop Relat Res (2006) 1.07
Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab (2009) 1.06
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem (2014) 1.06
Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry (2003) 1.04
Early outcome of a modular femoral component in revision total hip arthroplasty. J Arthroplasty (2007) 1.03
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants. J Rheumatol (2009) 1.02
DNA vaccines: are they still just a powerful tool for the future? Arch Immunol Ther Exp (Warsz) (2007) 1.02
Ultrahigh molecular weight polyethylene wear debris inhibits osteoprogenitor proliferation and differentiation in vitro. J Biomed Mater Res A (2009) 1.01
Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. J Reprod Immunol (2010) 1.01
Systemic trafficking of macrophages induced by bone cement particles in nude mice. Biomaterials (2008) 1.01
Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium. J Biomed Mater Res A (2012) 1.00
Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater (2004) 1.00
Human osteoblasts produce cathepsin K. Bone (2005) 1.00
Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol (2013) 0.99
Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. J Orthop Res (2011) 0.99
Dose- and time-dependent effects of cyclic hydrostatic pressure on transforming growth factor-beta3-induced chondrogenesis by adult human mesenchymal stem cells in vitro. Tissue Eng (2006) 0.99
Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine (2010) 0.99
Bone stress injuries of the lower extremity: a review. Acta Orthop Scand (2002) 0.98
Intraoperative passive kinematics of osteoarthritic knees before and after total knee arthroplasty. J Orthop Res (2006) 0.98
Surgical navigation for total knee arthroplasty: a perspective. J Biomech (2007) 0.97
Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol (2011) 0.97
Retroperitoneal hematoma: an unusual cause of pain after total hip arthroplasty. J Arthroplasty (2008) 0.97
Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury. J Orthop Res (2009) 0.97
Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A (2010) 0.96
Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome. Curr Rheumatol Rep (2003) 0.96
Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha. Cytokine (2004) 0.96
An in vivo murine model of continuous intramedullary infusion of polyethylene particles. Biomaterials (2008) 0.96
Averaging different alignment axes improves femoral rotational alignment in computer-navigated total knee arthroplasty. J Bone Joint Surg Am (2008) 0.96
Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation. Arthritis Rheum (2010) 0.96
Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surg Sports Traumatol Arthrosc (2012) 0.95
Dissociation of the femoral head and trunion after constrained conversion total hip arthroplasty for poliomyelitis. J Arthroplasty (2007) 0.95
Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res (2011) 0.95
Intermittent hydrostatic pressure inhibits matrix metalloproteinase and pro-inflammatory mediator release from human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage (2004) 0.95
Regulation of nitric oxide and bcl-2 expression by shear stress in human osteoarthritic chondrocytes in vitro. J Cell Biochem (2003) 0.95
Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis. Arthritis Rheum (2010) 0.95
Surveillance of systemic trafficking of macrophages induced by UHMWPE particles in nude mice by noninvasive imaging. J Biomed Mater Res A (2010) 0.94
Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells. Histochem Cell Biol (2008) 0.94
Cementless femoral prostheses cost more to implant than cemented femoral prostheses. Clin Orthop Relat Res (2008) 0.93
Basement membrane collagen type IV expression by human mesenchymal stem cells during adipogenic differentiation. J Cell Mol Med (2012) 0.93
Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med (2004) 0.93
Cemented total knee arthroplasty in patients with juvenile rheumatoid arthritis. Clin Orthop Relat Res (2005) 0.92